Abstract
Purpose: Giant Cell Myocarditis (GCM) is a rare but fatal form of myocarditis with a median survival time of less than 6 months in the absence of a transplant. Whether to transplant patients with GCM remains controversial as there are numerous case reports of recurrence in the transplanted heart and poor survival thought to be related to the disease recurrence. Long term survival, cardiac allograft vasculopathy (CAV), and freedom from non-fatal major adverse cardiac events (nf-MACE) have not been studied. We sought to determine the long-term outcomes of recipients who were unknowingly transplanted for GCM.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
